生命エネルギーを集約し

人類の健康を守る

すべて
  • すべて
  • 製品
  • ニュース
  • 内容を紹介する
  • 企業ギャラリー

証券コード: 603520


Jiangxi Starry annual production of 1,500 tons of triiodoisophthaloyl chloride change project (Phase 1 project) completed

2018-10-25

About Jiangxi Starry Pharmaceutical Co., Ltd.'s annual output of 1,500 tons of triiodoisophthaloyl chloride change project (Phase 1 project) completed
 
Pursuant to the requirements of laws and regulations of the Environmental Protection Law of the People's Republic of China and the “Environmental Management Regulations for Construction Projects” and other regulations, in order to extensively solicit and understand the public's change of Jiangxi Starry Pharmaceutical Co., Ltd.'s annual output of 1,500 tons of triiodoisophthaloyl chloride (Phase I) Opinions on the environmental protection acceptance of the completion of the project, the environmental protection acceptance information of the completion of the project is now published as follows:
 
First, the basic situation of the project
 
Project Name: Jiangxi Starry Pharmaceutical Co., Ltd. Annual Change Project of 1,500 Tons of Triiodoisophthaloyl Chloride (Phase I Project)
 
Construction unit: Jiangxi Starry Pharmaceutical Co., Ltd.
 
Construction site: North side of Wuyi Road, Salt Chemical Industry Base, Zhangshu City, Jiangxi Province
 
EIA compilation unit: Guangzhou Environmental Protection Engineering Design Institute Co., Ltd.
 
Acceptance report preparation unit: Jiangxi Hongji Engineering Consulting Co., Ltd.
 
Acceptance monitoring unit: Jiangxi Mengbaomei Environmental Testing Technology Co., Ltd.
 
Name and contact information of the construction unit
 
1. Name of construction unit: Jiangxi Starry Pharmaceutical Co., Ltd.
 
2. Address: North of Wuyi Road, Salt Chemical Industry Base, Zhangshu City, Jiangxi Province
 
3. Contact: Chen Weifei
 
4. Phone: 13858601166
 
Third, the main work of acceptance monitoring
 
(1) Exhaust gas emission monitoring; (2) Wastewater emission monitoring; (3) Noise emission monitoring; (4) Inspection of solid waste generation and disposal.
 
Fourth, the acceptance conclusion
 
Jiangxi Starry Pharmaceutical Co., Ltd. has completed 1500 tons of triiodoisophthaloyl chloride annual change project (Phase 1 project), complete the procedures, and better implemented the requirements of the environmental protection "three simultaneous" system. Letter, the acceptance data is basically complete, environmental protection measures have been basically completed in accordance with the requirements of the environmental impact assessment and approval, and the major pollutant indicators have reached the requirements of corresponding pollutant emission standards, meet the requirements of total volume control, meet the requirements of environmental protection facilities, and accept The group agreed that the project (Phase 1 project) passed the environmental protection acceptance of the completion.
 
V. Main Matters for Soliciting Public Opinion
 
In order to listen to the opinions and suggestions of all sectors of the society on the environmental protection work of the project, the inspection and monitoring of the project and the acceptance opinions are publicized (see the inspection report for the inspection in Annex 1 and the inspection opinions in Annex 2).
 
Publicity time: October 25th to November 23rd, 2018.
 
During the publicity period, if you have any objections to the above publicity content, please provide written feedback. Individuals must sign their real names and the company must affix their official seal.

関連ニュース

画像名